ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIV(mac)-Induced Immunodeficiency

類似資料

• Cervicovaginal Lamina Propria Lymphocytes: Phenotypic Characterization and Their Importance in Cytotoxic T-Lymphocyte Responses to Simian Immunodeficiency Virus SIV(mac251)
  著者:: Stevceva, Liljana, 等
  出版事項: (2002)
• Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV
  著者:: Ourmanov, Ilnour, 等
  出版事項: (2000)
• Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4(+) T-Cell Loss and Reduces both Systemic and Mucosal Simian-Human Immunodeficiency Virus SHIV(KU2) RNA Levels
  著者:: Pal, Ranajit, 等
  出版事項: (2006)
• Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIV(mac251): Dependence on Route of Challenge Exposure
  著者:: Benson, J., 等
  出版事項: (1998)
• Both Mucosal and Systemic Routes of Immunization with the Live, Attenuated NYVAC/Simian Immunodeficiency Virus SIV(gpe) Recombinant Vaccine Result in Gag-Specific CD8(+) T-Cell Responses in Mucosal Tissues of Macaques
  著者:: Stevceva, Liljana, 等
  出版事項: (2002)